Skip to main content
. 2019 Mar 27;106(6):711–719. doi: 10.1002/bjs.11127

Table 1.

Donor characteristics

All donors (n = 333) Donors with no pain (n = 251) Donors with pain (n = 82) P §
Age (years) * 56(11) 57(11) 53(11) 0·011
Sex ratio (M : F) 162 : 171 121 : 130 41 : 41 0·800
Height (cm) * 175(9) 175(9) 175(10) 0·692
Weight (kg) * 801(13) 81(12) 82(14) 0·450
BMI (kg/m 2 ) * 26·4(3·3) 26·4(3·2) 26·6(3·5) 0·616
BP (mmHg) *
Systolic 127(12) 128(12) 125(11) 0·132
Diastolic 76(9) 76(9) 76(8) 0·974
GFR (ml/min) * 111(22·2) 110(20·8) 114(26·2) 0·199
Type of donor 0·084#
Living related 139 (41·7) 98 (39·0) 41 (50)
Living unrelated 166 (49·8) 128 (51·0) 38 (46)
Altruistic 28 (8·4) 25 (10·0) 3 (4)
Side of donor nephrectomy 0·460
Right 80 (24·0) 63 (25·1) 17 (21)
Left 253 (76·0) 188 (74·9) 65 (79)
Intended surgical technique 0·426
HAL 314 (94·3) 238 (94·8) 76 (93)
HARN 19 (5·7) 13 (5·2) 6 (7)
Blood loss (ml) 0 (0–100) 0 (0–100) 0 (0–100) 0·674**
Duration of surgery (min) * 187(42) 186(42) 187(43) 0·880
Length of hospital stay (days) * 4·6(1·2) 4·5(1·1) 4·8(1·4) 0·033
Grade III–IV complications < 30 days 8 (2·4) 6 (2·4) 2 (2) 1·000
Conversion rate 0·338#
No conversion, primary HAL 313 (94·0) 237 (94·4) 76 (93)
No conversion, primary HARN 11 (3·3) 9 (3·6) 2 (2)
Conversion of HARN to HAL 8 (2·4) 4 (1·6) 4 (5)
Conversion of HAL to open 1 (0·3) 1 (0·4) 0 (0)
Need for reoperation 2 (0·6) 2 (0·8) 0 (0) 1·000
Follow‐up (months) 19 (10–33) 20 (12–33) 16 (8–32) 0·080**

Values in parentheses are percentages unless indicated otherwise; values are

*

mean(s.d.) and

median (i.q.r.).

Clavien–Dindo grade III–IV: any complication that requires surgical, endoscopic or radiological intervention. GFR, glomerular filtration rate; HAL, hand‐assisted laparoscopy; HARN, hand‐assisted retroperitoneal nephrectomy.

§

Fisher's exact test, except

Student's t test,

#

χ2 test and

**

Mann–Whitney U test.